Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

33%

2 of 6 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A

5(83.3%)

Phase 3

1(16.7%)

6Total

N/A(5)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT02358967Not ApplicableCompleted

Palm Tocotrienols in Chronic Hemodialysis (USA)

Role: collaborator

NCT02360748Not ApplicableCompleted

A Plant Based High Protein Diet to Improve Nutritional Outcomes in Peritoneal Dialysis Patients

Role: collaborator

NCT00561093Phase 3Completed

Anit-Inflammatory and Anti-Oxidative Nutrition in Dialysis Patients

Role: collaborator

NCT00692419Not ApplicableCompleted

Pain, Sexual Dysfunction, and Depression in Hemodialysis Patients

Role: collaborator

NCT00785629Not ApplicableCompleted

A Double Blind Randomized Placebo Trial of Maintenance of Normal Serum Phosphorus in CKD

Role: collaborator

NCT01116947Not ApplicableCompleted

Fosrenol for Enhancing Dietary Protein Intake in Hypoalbuminemic Dialysis Patients (FrEDI) Study

Role: collaborator

All 6 trials loaded